New FDA-Approved Treatment for RKD

The FDA has approved Ultomiris for adults with IgA Nephropathy (IgAN). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Juli Millas

Community Leader

Juli is from Tampa, Florida, and was originally diagnosed with Minimal Change Disease in July of 2002, when she was 36 years old. Three biopsies later, she was finally diagnosed with primary FSGS. Juli is steroid-resistant and finally went into remission for the first time in 2019. By trade, Juli is a licensed nail technician. She loves gardening, up-cycling pallets into furniture and home decor as a hobby, and loves, loves, loves giraffes.

NephCure Email: centralflorida@nephcurevolunteer.org

Central Florida

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.